The Secrecy in Pharmaceutical Industries in UAE law

Abstract

This research tries to reconcile two things on opposite sides, that is, the concept of secrecy as a condition of enforcement of the legal protection prescribed for inventions related to Pharmaceuticals on one hand, and on the other hand, the fact that the needs of the peoples of the third world or developing countries for drugs and treatment at reasonable and appropriate prices, to avoid suffering from chronic diseases and multiple epidemics. The secrecy, on one side is the weapon of the drug manufacturer of its monopoly and thus it can control the market for medicine and treatment, and on the other side, is a tool to prevent the most basic rights, which is the right to treatment and to maintain the integrity of the body and health of the peoples of developing countries. Therefore, a solution must be sought which takes into account the conflicting needs of the pharmaceutical companies and their consumers. Hence, this study is an attempt to show how the state, wishing to obtain the necessary drugs, can alleviate or mitigate the severity of the idea of secrecy and thus overcome the intransigence and arbitrariness, or at least the failure of the pharmaceutical companies to put these drugs on sale at reasonable prices that are suitable for low-income people.